Clidafidine

This classification denotes a sedative and hypnotic with the molecular formula C9H8Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6M04D93C96, chemically known as 2-((2,6-dichlorophenyl)-imino)oxazolidine. but generally known as clidafidine, which bears US NIH Compound Identifier 193994. European Medicines Agency schedules Clidafidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06658MIG. The term CLIDAFIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). CLIDAFIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clidafidine under HS 29349990 and SITC 51579. As of Q4 2014, CLIDAFIDINE remains the US FDA Preferred Term for this commodity. Clidafidine bears US NLM identifiers UMLS ID C2825295 and NCI Concept Code C80662. SMILES: CLC1C(NC2=NCCO2)C(CL)CCC1.